tiprankstipranks
Trending News
More News >
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989)
:9989
Hong Kong Market

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Similar Stocks

Compare
2 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
HK$5.19
HK$17.56B
16.80
36.94%
0 Buy
0 Hold
0 Sell
Moderate Sell
HUTCHMED (China)
HK$20.72
HK$18.07B
4.97
-7.09%
4 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Fosun Pharmaceutical (Group) Co
HK$20.52
HK$74.93B
15.62
48.80%
3 Buy
1 Hold
1 Sell
Moderate Buy
China Resources Pharmaceutical Group Ltd.
HK$4.57
HK$28.71B
9.44
-15.54%
1 Buy
0 Hold
0 Sell
Moderate Buy
CanSino Biologics, Inc. Class H
HK$44.94
HK$12.93B
-58.83
21.00%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:9989
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H
5.19
1.41
37.30%
HK:0013
HUTCHMED (China)
20.72
-1.58
-7.09%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
20.52
6.73
48.80%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.57
-0.94
-17.03%
HK:1558
HK:6185
CanSino Biologics, Inc. Class H
36.42
6.32
21.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts